论文信息 - Endocan or endothelial cell-specific molecule-1: a novel prognostic marker of sepsis? - 字舞流文

Endocan or endothelial cell-specific molecule-1: a novel prognostic marker of sepsis?

[1] J. Pugin,et al. Endocan, a new endothelial marker in human sepsis* , 2006, Critical care medicine.

[2] Peter A. Ward,et al. Novel strategies for the treatment of sepsis , 2003, Nature Medicine.

[3] John C. Marshall,et al. Such stuff as dreams are made on: mediator-directed therapy in sepsis , 2003, Nature Reviews Drug Discovery.

[4] B. Jude,et al. Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate Proteoglycan That Promotes Hepatocyte Growth Factor/Scatter Factor Mitogenic Activity* , 2001, The Journal of Biological Chemistry.

[5] H. Hammad,et al. Human Endothelial-Cell Specific Molecule-1 Binds Directly to the Integrin CD11a/CD18 (LFA-1) and Blocks Binding to Intercellular Adhesion Molecule-11 , 2001, The Journal of Immunology.

[6] V. Meignin,et al. Characterization of the Secreted Form of Endothelial-Cell-Specific Molecule 1 by Specific Monoclonal Antibodies , 2000, Journal of Vascular Research.

[7] R. Westendorp,et al. Anti-inflammatory cytokine profile and mortality in febrile patients , 1998, The Lancet.

[8] J. Parrillo. Pathogenetic mechanisms of septic shock. , 1993, The New England journal of medicine.